Zobrazeno 1 - 10
of 18
pro vyhledávání: '"KHIER DJABALLAH"'
Autor:
Philip D, Home, Rory J, McCrimmon, Julio, Rosenstock, Matthias, Blüher, Katrin, Pegelow, Lydie, Melas-Melt, Khier, Djaballah, Francesco, Giorgino
Publikováno v:
Diabetes, Obesity and Metabolism. 25:656-663
To report prespecified and post hoc analyses of the SoliMix dataset exploring the impact of baseline participant characteristics on the original SoliMix study outcomes, to enable informed treatment choices for people with different biomedical charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8aec36c52f748b8fa67635199e1ab7
https://doi.org/10.1111/dom.14907
https://doi.org/10.1111/dom.14907
Autor:
Rory J. McCrimmon, Alice Y.Y. Cheng, Gagik Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert, Juan P. Frias
Publikováno v:
Diabetes, Obesity and Metabolism. 25:68-77
For people with suboptimally controlled type 2 diabetes (T2D) on basal insulin (BI), guidelines recommend several treatment advancement options. This study compared the clinical effectiveness of once-daily iGlarLixi versus a multiple-injection BI + r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e3e4172c3738fa4b487cc97bbd9665
https://doi.org/10.1111/dom.14844
https://doi.org/10.1111/dom.14844
Autor:
Philip D. Home, Julio Rosenstock, Francesco Giorgino, Matthias Blüher, Thorsten Siegmund, Khier Djaballah, Katrin Pegelow, Lydie Melas-Melt, Rory J. McCrimmon
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4c3f6e8cb96fbf75457a8f45a1a561b
https://doi.org/10.1055/s-0043-1768001
https://doi.org/10.1055/s-0043-1768001
Autor:
Rory J. McCrimmon, Alice Y.Y. Cheng, Robert Ritzel, Gagik Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert, Juan Frías
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73957574e4c9618e89253893a2b3624a
https://doi.org/10.1055/s-0043-1768002
https://doi.org/10.1055/s-0043-1768002
Autor:
null Philip D. Home, null Rory J. McCrimmon, null Julio Rosenstock, null Matthias Blüher, null Katrin Pegelow, null Lydie Melas‐Melt, null Khier Djaballah, null Francesco Giorgino, null the SoliMix trial investigators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d68e8d570a2f53dc8df75c0792d2129c
https://doi.org/10.1111/dom.14907/v2/response1
https://doi.org/10.1111/dom.14907/v2/response1
Autor:
PHILIP HOME, JULIO ROSENSTOCK, FRANCESCO GIORGINO, MATTHIAS BLÜHER, KHIER DJABALLAH, KATRIN PEGELOW, LYDIE MELAS-MELT, RORY J. MCCRIMMON
Publikováno v:
Diabetes. 71
Introduction: SoliMix (EudraCT: 2017-003370-13) found better HbA1c, weight benefit, and lower hypoglycemia risk with iGlarLixi vs. premix BIAsp 30 in people with type 2 diabetes (T2D) advancing from basal insulin (BI) + oral antihyperglycemic drugs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fbd6bee110b7e242d9f5f73c283e7e4
https://doi.org/10.2337/db22-846-p
https://doi.org/10.2337/db22-846-p
Autor:
PHILIP HOME, RORY J. MCCRIMMON, JULIO ROSENSTOCK, MATTHIAS BLÜHER, KATRIN PEGELOW, LYDIE MELAS-MELT, KHIER DJABALLAH, FRANCESCO GIORGINO
Publikováno v:
Diabetes. 71
Introduction: SoliMix (EudraCT: 2017-003370-13) found better HbA1c, weight benefit, and lower hypoglycemia risk requiring less insulin with once-daily iGlarLixi vs. twice-daily premix BIAsp 30 in people with type 2 diabetes (T2D) advancing from basal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f7dde1ec478739d630ad113fbfceb70
https://doi.org/10.2337/db22-845-p
https://doi.org/10.2337/db22-845-p
Autor:
RORY J. MCCRIMMON, ALICE Y. CHENG, GAGIK R. GALSTYAN, KHIER DJABALLAH, XUAN LI, MATHIEU COUDERT, JUAN PABLO FRIAS
Publikováno v:
Diabetes. 71
Introduction: Indirect evidence suggests iGlarLixi is as efficacious as basal insulin (BI) + rapid acting insulin (RAI) for management of type 2 diabetes (T2D) . However, there are no direct comparisons of iGlarLixi (once-daily [QD]) vs. a BI+RAI reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78dc4cc534d9d450be19f2f939137499
https://doi.org/10.2337/db22-260-or
https://doi.org/10.2337/db22-260-or
Autor:
Kamlesh Khunti, León Litwak, Freddy Goldberg-Eliaschewitz, Shih-Te Tu, Pablo Aschner, Khadija Hafidh, Guillermo Gonzalez-Galvez, Ambika Gopalakrishnan Unnikrishnan, Khier Djaballah, Dilek Gogas Yavuz, Gagik Radikovich Galstyan
Publikováno v:
Diabetes Therapy
Introduction Trends on glycemic control and diabetes complications are known for high-income countries, but comprehensive data from low- and middle-income countries (LMIC) are lacking. Methods This is an expert opinion based on two retrospective stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8feaddf3f4cc5e46c3965ca8ea9dde6
https://doi.org/10.1007/s13300-021-00997-0
https://doi.org/10.1007/s13300-021-00997-0
Autor:
Naim Shehadeh, Monira Al Arouj, Faris Abdul Kareem Khazaal, Cecile Dessapt-Baradez, Khier Djaballah, Akram Echtay, Khaled El Sayed El Hadidy, Abdulrahman Al Shaikh, Mohamed Hassanein, Mohamad Omar Abu-Hijleh, Mohamed El Hassan Gharbi, Sobia Sabir Ali, Abdullah Bennakhi, Fatheya F. Al Awadi
Publikováno v:
Advances in Therapy
Introduction To describe the characteristics and care of participants with type 1 diabetes during Ramadan in the Middle East and North Africa. Methods The DAR-MENA (Diabetes and Ramadan—Middle East and North Africa) study was a prospective, observa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b944ce604db09366a90987bf95f87e94
http://europepmc.org/articles/PMC7140750
http://europepmc.org/articles/PMC7140750